TSTickerStarGet alerts
Company alerts/MDCX
MDCX company alerts

MDCX updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for MDCX. Subscribe to MDCX alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Subscribe for MDCX alertsView companies
Official-source feed

Recent MDCX alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

Company updateOfficial company source

Medicus proposes $135 million pre-money SkinJect business combination with undisclosed SPAC

Medicus Pharma Ltd.'s wholly owned subsidiary SkinJect, Inc. entered a non-binding letter of intent with an undisclosed special purpose acquisition company for a proposed business combination that contemplates a $135 million pre-money enterprise valuation for SkinJect and a concurrent equity financing. The SPAC would acquire 100% of SkinJect in exchange for newly issued common shares of the combined company, with Medicus seeking to retain majority economic and voting ownership of a separately listed company. The...

Read source-backed brief
Company updateOfficial company source

Medicus proposes $135 million SkinJect business combination and concurrent financing

Medicus Pharma announced that SkinJect entered a non-binding letter of intent with an undisclosed SPAC for a proposed business combination valuing SkinJect at a $135 million pre-money enterprise valuation. The SPAC would acquire 100% of SkinJect for newly issued common shares of the combined company, with Medicus seeking to retain majority economic and voting ownership. A concurrent equity financing would support SKNJCT-005 and preparation of a potential New Drug Application; completion is anticipated during the...

Read source-backed brief
Debt offeringSEC filing

Medicus Pharma Ltd. effects 1-for-50 share consolidation effective October 12, 2026

Medicus Pharma Ltd. effected a 1-for-50 share consolidation of its issued and outstanding common shares, no par value, effective October 12, 2026, by filing Articles of Amendment with the Ontario Ministry of Public and Business Service Delivery. The consolidation was approved by shareholders at the June 3, 2026 Annual General and Special Meeting and unanimously approved by the Board at a 1-for-50 ratio on September 24, 2026. Proportionate adjustments were made to the exercise or conversion prices and the number...

Read source-backed brief